In 2022, MEDIPAL continued its policy of expanding the geography of its presence and opened 2 representative offices in Uzbekistan and the Republic of Belarus.
The Representative Offices aim at promoting in-demand medicines in the OTC segment (over-the-counter medicines), developing and strengthening mutually beneficial cooperation under a partnership agreement with Sanofi.
Since 2014, MEDIPAL has been actively working to develop the export of products of the largest pharmaceutical manufacturers and to provide access for patients to high-quality medicines at the highest level. Sanofi is one of the world leaders in healthcare, developing and implementing therapeutic solutions to meet the various needs of patients.
The company’s vision rests on the following principles of growth: modern solutions to treat diabetes mellitus, human vaccines, innovative medicines, over-the-counter drugs, health products, emerging markets, and veterinary drug products.